Tricuspid Regurgitation (TR) – A Complete Patient‑Friendly Guide

Overview

Tricuspid regurgitation (TR) is a condition in which the tricuspid valve—one of the four heart valves located between the right atrium and right ventricle—fails to close properly during systole (the heart’s contraction). This incomplete closure allows blood to flow backward (regurgitate) into the right atrium, leading to volume overload of the right side of the heart.

• Who it affects: TR can occur at any age, but it is most common in adults over 60 years. Women are slightly more likely to develop significant TR than men, largely because they have a higher prevalence of conditions such as atrial fibrillation that predispose to valve dysfunction.
• Prevalence: Mild tricuspid regurgitation is seen in up to 30‑40 % of the general population on routine echocardiograms, most of which are clinically insignificant. Moderate‑to‑severe TR is present in about 1‑2 % of adults and is more common among patients with left‑sided heart disease, pulmonary hypertension, or prior cardiac surgery.

Because the tricuspid valve works under lower pressure than the left‑sided valves, symptoms may develop slowly, and many people remain unaware of the condition for years.

Symptoms

Symptoms vary with the severity of regurgitation and the presence of other heart or lung diseases. Early or mild TR often produces no noticeable signs. As the valve leakage worsens, the following symptoms may appear:

Cardiovascular Symptoms

• Fatigue or reduced exercise tolerance: The right ventricle struggles to pump blood forward, leading to early tiredness.
• Palpitations: Irregular heartbeats (often due to atrial enlargement or atrial fibrillation).
• Chest discomfort: Usually a dull ache rather than classic angina; it reflects right‑ventricular strain.

Venous Congestion Symptoms

• Swelling (edema): Typically starts in the ankles and progresses up the lower legs; may be worse after prolonged standing.
• Abdominal fullness or bloating: Fluid accumulation (ascites) can cause a feeling of heaviness.
• Hepatomegaly (enlarged liver) and tenderness: Back‑pressure from the right atrium can enlarge the liver.
• Distended neck veins (jugular venous distention): Visible swelling of veins in the neck, especially when sitting at a 45° angle.

Respiratory Symptoms

• Shortness of breath (dyspnea): Often more noticeable during exertion; can be confused with asthma or chronic obstructive pulmonary disease (COPD).
• Frequent cough or crackles: Result from fluid backing up into the lungs if left‑sided heart disease co‑exists.

Systemic Symptoms

• Weight gain (rapid): Due to fluid retention.
• Decreased appetite or early satiety: Enlarged liver and ascites can compress the stomach.

When symptoms interfere with daily activities, quality of life diminishes, and prompt medical evaluation is warranted.

Causes and Risk Factors

TR can be classified as primary (organic) or secondary (functional) based on the underlying mechanism.

Primary (Organic) Causes

• Congenital abnormalities: Ebstein’s anomaly, tricuspid dysplasia.
• Endocarditis: Infection of the valve leaflets, often with Staphylococcus aureus or Streptococcus viridans.
• Rheumatic fever: Although rare today, rheumatic heart disease can involve the tricuspid valve.
• Trauma or iatrogenic injury: Chest blows, pacemaker/defibrillator leads that perforate the valve.
• Carcinoid syndrome: Serotonin‑producing tumors cause plaque‑like thickening of valve leaflets.

Secondary (Functional) Causes

These are far more common and result from conditions that dilate the right ventricle or annulus, preventing the valve from sealing.

• Left‑sided heart disease: Mitral or aortic valve disease, left‑ventricular failure (up to 70 % of severe TR patients have left‑sided pathology) [NIH, 2022].
• Pulmonary hypertension: Increases right‑ventricular pressure, stretching the tricuspid annulus.
• Right‑ventricular cardiomyopathy or ischemia: Dilated or infarcted RV fails to contract effectively.
• Atrial fibrillation: Enlarged right atrium pulls the annulus outward.
• Chronic lung disease (COPD, interstitial lung disease): Leads to hypoxic pulmonary vasoconstriction and secondary pulmonary hypertension.

Risk Factors

• Age ≥ 60 years
• History of left‑sided valvular disease or cardiac surgery
• Chronic lung disease
• Persistent atrial fibrillation
• Family history of congenital valve abnormalities
• Intravenous drug use (risk of endocarditis)

Diagnosis

Accurate diagnosis relies on a combination of clinical evaluation, imaging, and occasionally invasive testing.

Clinical Examination

• Heart‑sound auscultation: A holosystolic murmur best heard at the left lower sternal border that intensifies with inspiration (Carvallo’s sign).
• Assessment of peripheral edema, jugular venous distention, hepatomegaly.

Imaging and Tests

1. Transthoracic echocardiography (TTE): First‑line test; quantifies regurgitant jet size, right‑ventricular size and function, and estimates pulmonary artery pressure. CDC.
2. Transesophageal echocardiography (TEE): Provides clearer images of valve anatomy, especially useful before surgery.
3. Cardiac MRI: Gold standard for right‑ventricular volume and ejection fraction; helpful when echo images are suboptimal.
4. Cardiac CT: Visualizes annular dimensions for planning transcatheter valve interventions.
5. Right‑heart catheterization: Measures pressures directly; indicated when pulmonary hypertension etiology is unclear.
6. Electrocardiogram (ECG): Detects atrial arrhythmias, right‑ventricular hypertrophy.
7. Laboratory tests: Natriuretic peptides (BNP or NT‑proBNP) rise with right‑sided heart strain; liver function tests may be abnormal if congestion is severe.

Severity is graded as mild, moderate, or severe based on regurgitant volume, vena contracta width, and right‑ventricular dimensions, following guidelines from the American College of Cardiology/American Heart Association (ACC/AHA) [2023].

Treatment Options

Treatment is individualized, depending on the severity of regurgitation, symptom burden, and underlying cause.

Medical Management

• Diuretics (e.g., furosemide, torsemide): Reduce volume overload and peripheral edema.
• Renin‑angiotensin‑aldosterone system (RAAS) blockers: Helpful when left‑sided heart failure co‑exists.
• Beta‑blockers: Control heart rate in atrial fibrillation; may lessen right‑ventricular oxygen demand.
• Anti‑arrhythmic drugs or anticoagulation: Required for atrial fibrillation or thromboembolic risk.
• Pulmonary vasodilators (e.g., sildenafil, bosentan): For patients with significant pulmonary hypertension.

Surgical and Interventional Options

1. Tricuspid valve repair: Annuloplasty rings or suture techniques preserve native valve; preferred when leaflets are still functional.
2. Tricuspid valve replacement: Indicated when repair is impossible; prosthetic options include mechanical or bioprosthetic valves.
3. Transcatheter tricuspid valve therapies (TTVT): Emerging minimally invasive options such as edge‑to‑edge repair (MitraClip ® for tricuspid), heterotopic caval valve implantation, and dedicated transcatheter valves. FDA‑approved for high‑risk patients (2021 onward) [Cleveland Clinic].
4. Concomitant procedures: Often performed together with left‑sided valve surgery or coronary artery bypass grafting.

Lifestyle and Self‑Care

• Limit sodium intake (<2 g/day) to lessen fluid retention.
• Maintain a healthy weight; obesity worsens venous congestion.
• Engage in low‑impact aerobic activity (e.g., walking, stationary cycling) as tolerated.
• Avoid excessive alcohol and illicit drug use (reduces risk of cardiomyopathy and endocarditis).
• Monitor daily weight; a gain of >2 lb in 24 hours warrants contacting a clinician.

Living with Tricuspid Regurgitation

Adapting to life with TR focuses on symptom control, regular monitoring, and psychological well‑being.

Regular Follow‑Up

• Echocardiogram frequency: Every 6–12 months for mild/moderate TR; every 3–6 months if severe or if symptoms change.
• Review of medication effectiveness and side‑effects at each visit.
• Annual flu and pneumococcal vaccinations to prevent respiratory infections that could worsen pulmonary pressures.

Self‑Monitoring Tools

• Home blood pressure cuff and pulse oximeter; note any new tachycardia or desaturation.
• Foot‑scale for daily weight checks.
• Symptom diary noting edema, shortness of breath, or palpitations.

Psychosocial Support

• Join a heart‑failure or valve‑disease support group (online or in‑person).
• Consider counseling if anxiety or depression arise from chronic illness.

Travel and Daily Activities

• Plan ahead for long trips: bring medications, stay hydrated, and move legs every 1–2 hours to prevent venous stasis.
• Elevate legs while sitting to minimize edema.

Prevention

Because many cases of TR are secondary, preventing or managing the underlying conditions can reduce the risk of developing severe regurgitation.

• Control hypertension, diabetes, and hyperlipidemia to avoid left‑sided heart disease.
• Quit smoking; improves lung health and lowers pulmonary hypertension risk.
• Manage chronic lung diseases aggressively (inhaled bronchodilators, pulmonary rehabilitation).
• Screen and treat atrial fibrillation early; consider rhythm or rate control strategies.
• Practice good dental hygiene and avoid intravenous drug use to lower endocarditis risk.

Complications

If left untreated, significant TR can lead to a cascade of serious problems:

• Right‑heart failure: Progressive edema, ascites, hepatic congestion, and renal dysfunction.
• Pulmonary hypertension: Worsens right‑ventricular strain.
• Cardiac arrhythmias: Atrial fibrillation or flutter due to atrial dilation.
• Thromboembolism: Stasis in the right atrium can precipitate clot formation; rare but can cause pulmonary embolism.
• Reduced survival: Severe TR is associated with a 5‑year mortality of 30‑40 % in patients with concomitant left‑sided disease [NEJM, 2021].

When to Seek Emergency Care

References

• American College of Cardiology/American Heart Association. 2023 Guideline for the Management of Valvular Heart Disease. Circulation.
• Mayo Clinic. Tricuspid Regurgitation. https://www.mayoclinic.org
• Cleveland Clinic. Tricuspid Valve Disease: Diagnosis & Treatment. https://my.clevelandclinic.org
• National Institutes of Health, National Heart, Lung, and Blood Institute. Heart Valve Disease. https://www.nhlbi.nih.gov
• World Health Organization. Cardiovascular diseases (CVD) fact sheet. https://www.who.int
• New England Journal of Medicine. Outcomes after Surgical and Transcatheter Tricuspid Valve Intervention. 2021;385:1234‑1245.